The anti-obesity agent Orlistat is associated to increase in colonic preneoplastic markers in rats treated with a chemical carcinogen

Cancer Letters

Volumn 240, Issue 2, 2006, Pages 221-224

  Garcia, Sérgio Britto ^a   da Costa Barros, Luane Taísa ^a   Turatti, Aline ^a   Martinello, Flávia ^a   Modiano, Patrícia ^a   Ribeiro Silva, Alfredo ^a   de Oliveira Vespúcio, Marcelo Vinícius ^a   Uyemura, Sérgio Akira ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Aberrant Crypt Foci; Colon carcinogenesis; Orlistat; PCNA

Indexed keywords

ANTIOBESITY AGENT; CARCINOGEN; CYCLINE; DIMETHYLHYDRAZINE; TETRAHYDROLIPSTATIN;

ABERRANT CRYPT FOCUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; COLON CANCER; COLON CARCINOGENESIS; COLON DISEASE; CONTROLLED STUDY; DIET; INTESTINE CRYPT; LIPID DIET; MALE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; RAT; STANDARD;

1,2-DIMETHYLHYDRAZINE; ANIMALS; ANTI-OBESITY AGENTS; CARCINOGENS; CELL PROLIFERATION; COLONIC NEOPLASMS; INTESTINAL MUCOSA; LACTONES; LIPASE; MALE; PRECANCEROUS CONDITIONS; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, WISTAR;

ANIMALIA; RATTUS NORVEGICUS;

EID: 33746268317     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.09.011     Document Type: Article

References (23)

1. Harp J.B. Orlistat for the long-term treatment of obesity. Drugs Today 35 (1999) 139-145
2. Ballinger A., and Peikin S.R. Orlistat: its current status as an anti-obesity drug. Eur. J. Pharmacol. 440 (2002) 109-117
3. Heck A.M., Yanovski J.A., and Calis K.A. Orlistat, a new lipase inhibitor for the management of obesity. Pharmacotherapy 20 (2000) 270-279
4. Guerciolini R., Radu-Radulescu L., Boldrin M., Dallas J., and Moore R. Comparative evaluation of fecal fat excretion induced by orlistat and chitosan. Obes. Res. 9 (2001) 364-367
5. Nishioka T., Hafkamp A.M., Havinga R., vn Lierop P.P., Velvis H., and Verkade H.J. Orlistat treatment increases fecal bilirubin excretion and decreases plasma bilirubin concentrations in hyperbilirubinemic gunn rats. J. Pediatr. 143 (2003) 327-334
6. Morotomi M., Sakaitani Y., Satou M., Takahashi T., Takagi A., and Onoue M. Effects of a high-fat diet on azoxymethane-induced aberrant crypt foci and fecal biochemistry and microbial activity in rats. Nutr. Cancer. 27 (1997) 84-91
7. Newmark H.L., Yang K., Lipkin M., Kopelovich L., Liu Y., Fan K., and Shinozaki H.A. Western-style diet induces benign and malignant neoplasms in the colon of normal C57Bl/6 mice. Carcinogenesis 22 (2001) 1871-1875
8. Thornton Jr. W.H., and MacDonald R.S. Dietary fat quantity and composition induce changes in proliferation and membrane lipids in rat colon cells. Ann. Nutr. Metab. 41 (1997) 260-268
9. Shpitz B., Bomstein Y., Mekori Y., Cohen R., Kaufman Z., Grankin M., and Bernheim J. Proliferating cell nuclear antigen as a marker of cell kinetics in aberrant crypt foci, hyperplastic polyps, adenomas, and adenocarcinomas of the human colon. Am. J. Surg. 174 (1997) 425-430
10. Geter D.R., George M.H., Moore T.M., Kilburn S.R., Huggins-Clark G., and DeAngelo A.B. The effects of a high animal fat diet on the induction of aberrant crypt foci in the colons of male F344/N rats exposed to trihalomethanes in the drinking water. Toxicol. Lett. 147 (2004) 245-252
11. Hafkamp A.M., Havinga R., Sinaasappel M., and Verkade H.J. Effective oral treatment of unconjugated hyperbilirubinemia in gunn rats. Hepatology 41 (2005) 526-534
12. Piva-Demarzo M.M., and Garcia S.B. Exhaustive physical exercise increases the number of colonic preneoplastic lesions in untrained rats treated with a chemical carcinogen. Cancer Lett. 216 (2004) 31-34
13. Bays H., and Dujovne C. Pharmacotherapy of obesity: currently marketed and upcoming agents. Am. J. Cardiovasc. Drugs 2 (2002) 245-253
14. Erhardt J.G., Lim S.S., Bode J.C., and Bode C. A diet rich in fat and poor in dietary fiber increases the in vitro formation of reactive oxigen species in human feces. J. Nutr. 127 (1997) 706-709
15. Bull A.W., Nigro N.D., Golembieski W.A., Crissman J.D., and Marnett L.J. In vivo stimulation of DNA synthesis and induction of ornithine decarboxylase in rat colon by fatty acid hydroperoxides, autoxidation products of unsaturated fatty acids. Cancer Res. 44 (1984) 4924-4928
16. Salim A.S. The permissive role of oxygen-derived free radicals in the development of colonic cancer in the rat. A new theory for carcinogenesis. Int. J. Cancer 53 (1993) 1031-1035
17. Singh J., Hamid R., and Reddy B.S. Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. Cancer Res. 57 (1997) 3465-3470
18. Rao C.V., Hirose Y., Indranie C., and Reddy B.S. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res. 61 (2001) 1927-1933
19. Melia A.T., Koss-Twardy S.G., and Zhi J. The effect of orlistat, an inhibitor of dietary fat absorption, on the absorption of vitamins A and E in healthy volunteers. J. Clin. Pharmacol. 36 (1996) 647-653
20. Shivapurkar N., Tang Z., Frost A., and Alabaster O. Inhibition of progression of aberrant crypt foci and colon tumor development by vitamin E and beta-carotene in rats on a high-risk diet. Cancer Lett. 91 (1995) 125-132
21. Harris D.M., and Go V.L. Vitamin D and colon carcinogenesis. J. Nutr. 134 (2004) 3463S-3471S
22. Kridel S.J., Axelrod F., Rozenkrantz N., and Smith J.W. Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity. Cancer Res. 64 (2004) 2070-2075
23. Padwal R., Li S.K., and Lau D.C. Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials. Int. J. Obes. Relat. Metab. Disord. 27 (2003) 1437-1446